Pharmaron Revenue and Competitors
Estimated Revenue & Valuation
- Pharmaron's estimated annual revenue is currently $208.6M per year.
- Pharmaron's estimated revenue per employee is $115,333
- Pharmaron's total funding is $907.8M.
Employee Data
- Pharmaron has 1809 Employees.
- Pharmaron grew their employee count by 9% last year.
Pharmaron's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | Executive Director and Head Europe Business Development, Pharmaron | Reveal Email/Phone |
6 | EVP | Reveal Email/Phone |
7 | SVP Medicinal Chemistry | Reveal Email/Phone |
8 | SVP, Business and Corporate Development | Reveal Email/Phone |
9 | VP, Cheminformatics and Comp. Chem. | Reveal Email/Phone |
10 | SVP DMPK | Reveal Email/Phone |
Pharmaron Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Pharmaron?
Pharmaron is a premier R&D service provider for the pharmaceutical industry. Founded in 2003, Pharmaron has invested in our people and our facilities enabling us to provide high quality R&D service across a number of disciplines including chemistry, biology, DMPK, pharmacology and chemical development. Pharmaron has grown steadily to meet the needs of our customers.
keywords:Biotechnology$907.8M
Total Funding
1809
Number of Employees
$208.6M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pharmaron News
Charles River Laboratories, Pharmaceutical Product Development (PPD), Pharmaron, Albany Molecular Research (AMRI), Galapagos, Tecan Group. The...
Pharmaron has taken their platform beyond small molecules and are pleased to now offer a full array of services for biologics and cell and...
Pharmaron Beijing Co., Ltd.* (a joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 3759 2020 INTERIM REPORT For identification purposes only Premier R&D service provider for the life sciences industry About Pharmaron Pharmaron is a pre ...
Pharmaron, a Beijing, China-based contract research organization (CRO), received an over US$280m investment. The consortium was led by CITIC M&A Fund and Legend Capital. The company intends to use the funds to further strengthen its core R&D service platforms to expand its existing R&D capabil ...
Irvine-based Pharmaron, a provider of R&D services to the pharmaceutical and biotech industry, said last week that it has raised $40M in a Series C funding round. The round came from DCM, Legend Capital, GL Capital Group, and others. The firm said the new funding will go to expand its discovery ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $710.3M | 1879 | 41% | N/A |
#2 | $681.6M | 1898 | N/A | N/A |
#3 | $735.9M | 1906 | 2% | $21.7M |
#4 | $478M | 1951 | 30% | N/A |
#5 | $737.9M | 1952 | 4% | N/A |